The field of nicotine psychopharmacology has rapidly expanded in recent years, driven by theoretical, pharmaceutical and tobacco-related interests. It was challenging to represent the many promising areas of research, from molecular to clinical to epidemiological, within a single volume.
This book provides relatively focused reviews written by leading researchers on their areas of recent interest. Each article was reviewed by experts, producing a reference that will be useful to researchers, students, health professionals, and to the growing number of people involved in efforts to regulate tobacco product contents and designs nationally and internationally.